Published October 2010 | Version v1
Journal article

Helical tomo-therapy of ORL cancers: prospective scintigraphic assessment of parotid gland protection

  • 1. Departement d'oncologie-radiotherapie, institut Curie, 75 - Paris (France)
  • 2. Departement de biostatistiques, institut Curie, 75 - Paris (France)
  • 3. Departement de medecine nucleaire, institut Curie, 75 - Paris (France)
  • 4. Departement de chirurgie, service d'ORL, institut Curie, 75 - Paris (France)
  • 5. Universite Paris Descartes, 75 - Paris (France)
  • 6. Service d'oncologie-radiotherapie, hopital europeen Georges-Pompidou, 75 - Paris (France)

Description

The authors discuss data and results of treatments performed on 19 patients suffering from ORL cancers and submitted to helical tomo-therapy in order to protect their parotid glands. They discuss the planning target volume coverage and the assessment of the salivary excretion fraction by scintigraphy before, and six months and twelve months after the tomography. It appears that the helical tomography protects the parotid glands, thus reducing the incidence and severity of xerostomia by 6 and 12 months. The authors indicate a threshold average dose for the protection of gland functionality. Short communication

Availability note (English)

Available from doi:

Additional details

Additional titles

Original title (French)
La tomotherapie helicoidale des cancers ORL: evaluation scintigraphique prospective de la preservation des glandes parotides

Identifiers

Publishing Information

Journal Title
Cancer Radiotherapie
Journal Volume
14
Journal Issue
no.6-7
Journal Page Range
p. 605
ISSN
1278-3218
CODEN
CARAFC

Conference

Title
21. national congress of the French society of oncological radiotherapy
Original Conference Title
21. Congres national de la Societe Francaise de Radiotherapie Oncologique (SFRO)
Dates
6-8 Oct 2010
Place
Paris (France)